Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI™ (lecanemab-irmb) for the Treatment of Alzheimer's Disease
ADDF STATEMENT ON FDA ACCELERATED APPROVAL OF LECANEMAB (LEQEMBI)
Ligand's Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
Global Spinal Muscular Atrophy Treatment Market Report 2022: Growing R&D Activities for Treatments Boosts Sector - ResearchAndMarkets.com
BiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Global Spinal Muscular Atrophy Treatment Market Report 2022: Increasing Reimbursement Access To Patients Bolsters Growth
MediciNova to Meet with U.S. FDA to Discuss Clinical Development of a Parenteral Formulation of MN-166 (ibudilast)
 14   15   16   17   18     19    20   21   22   23   24 
 <<   <   >   >>